Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion

26-Feb-2019 - Danaher Corporation announced that it has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction ...

GE Launches $250 Million Healthymagination Fund

New equity investment fund to invest in high potential healthcare technology companies

26-Oct-2009 - GE announced the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the ...

Quotient Bioresearch acquires radiochemical custom synthesis operations from GE Healthcare

Major investment in new radiochemicals facility to be located in Cardiff, Wales

30-Jun-2009 - Quotient Bioresearch Limited announced that it has reached an agreement to acquire Amersham Radiolabelling Services, the radiochemical custom synthesis operations of GE Healthcare. This represents Quotient’s seventh acquisition since its formation in early 2007. According to the company, this ...

GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences

Global alliance in biomolecular imaging

02-Jun-2009 - GE Healthcare, a unit of General Electric Company, announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold ...

European research project tp explore Alzheimer's disease diagnosis

09-Jun-2008 - VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's ...

GE Healthcare completes acquisition of Whatman plc

29-Apr-2008 - GE Healthcare, a unit of General Electric Company announced that it has completed the acquisition of Whatman plc, a global supplier of filtration products and technologies. The acquisition expands GE Healthcare's offering for life science research and biopharmaceutical manufacturing. GE ...

GE Healthcare and Novavax establish collaboration to develop and market pandemic influenza solution

Collaboration aimed at enabling vaccine production facility commissioning in half the time of a traditional egg-based facility

12-Dec-2007 - GE Healthcare, a unit of General Electric Company, and Novavax Inc. announced a collaboration agreement to develop and market a pandemic influenza vaccine manufacturing solution for selected international countries. This collaboration leverages GE Healthcare's bioprocess solutions and design ...

GE Healthcare grants license for biomagnetic isolation of nucleic acids to NorDiag ASA

07-May-2007 - GE Healthcare, a unit of General Elecrtic, announced that it has completed a license agreement with NorDiag ASA, granting NorDiag ASA access to GE Healthcare patents for the biomagnetic isolation of nucleic acids. The license, which is valid for the lifetime of the patents, grants NorDiag ASA ...

GE Healthcare Acquires Wave Biotech LLC

Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment

18-Apr-2007 - GE Healthcare, a unit of General Electric Company, announced it has acquired Wave Biotech LLC, a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition of Wave Biotech LLC including its subsidiary Wave Europe Pvt. Ltd. shall allow GE Healthcare to ...

GE Healthcare and BAC start collaboration in biopharmaceutical purification

24-Oct-2006 - GE Healthcare and BAC BV announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area. Under the terms of the agreement, the two companies plant to develop new affinity chromatography media for human antibodies and adeno-associated virus ...